We need to better safeguard our Nation's drug supply but we need to make sure whatever legislation we enact actually achieves that goal, it doesn't just give people the hope that someday we will achieve it.
Pitts emphasizes the importance of effective legislation for drug supply safety.
Share
More from Joe Pitts
In 2008, Congress passed a bill requiring most group health plans to provide more generous coverage for treatment of mental illnesses.
H.R. 1807, the Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015, sponsored by Rep. Danny Davis (IL) and Rep. Michael Burgess (TX) reauthorizes a sickle cell disease demonstration program.
I applaud the cosponsors for working through the committee to address serious stakeholder concerns by taking a new approach in the draft we are discussing today.
So, moving forward, the committee welcomes feedback on how we can improve care for children with medical complexity without disrupting the successful approaches already in place.
Other voices in this conversation
